Whole-body hybrid PET/MRI: Ready for clinical use?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 6, 2011, Pages 992-995

  Ratib, Osman ^a   Beyer, Thomas ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b cmi experts GmbH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; HUMAN; IMAGING SYSTEM; REVIEW; WHOLE BODY MRI; WHOLE BODY PET;

HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SYSTEMS INTEGRATION; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 79958076954     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1790-4     Document Type: Review

References (22)

1. Townsend DW, Beyer T, Kinahan PE, Meltzer CC, Brun T, Nutt R, et al. The SMART Scanner: A combined PET/CT tomograph for clinical oncology. Radiology. 1998;209P:169-70.
2. CD Collins 2007 PET/CT in oncology: for which tumours is it the reference standard? Cancer Imaging 7 Spec No A S77 S87 17921085 10.1102/1470-7330.2007. 9008 (Pubitemid 350200309)
3. MN Lonsdale T Beyer 2010 Dual-modality PET/CT instrumentation - today and tomorrow Eur J Radiol 73 452 460 20096520 10.1016/j.ejrad.2009.12.021
4. G Antoch N Saoudi H Kuehl G Dahmen SP Mueller T Beyer, et al. 2004 Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET J Clin Oncol 22 4357 4368 15514377 10.1200/JCO.2004.08.120 (Pubitemid 41185156)
5. R Bar-Shalom N Yefremov L Guralnik D Gaitini A Frenkel A Kuten, et al. 2003 Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management J Nucl Med 44 1200 1209 12902408 (Pubitemid 39655178)
6. G Antoch A Bockisch 2009 Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging 36 Suppl 1 S113 S120 19104802 10.1007/s00259-008-0951-6
7. X Liang W Congxin Z Yi H Jinwen L Chuanfu 2010 Whole-body diffusion-weighted MR imaging with fat suppression by using STIR: Clinical utility for detection of primary malignancies in patients initially presented with metastasis Eur J Radiol 10.1016/j.ejrad.2010.02.013
8. BJ Pichler A Kolb T Nagele HP Schlemmer 2009 PET/MRI: paving the way for the next generation of clinical multimodality imaging applications J Nucl Med 51 333 336 10.2967/jnumed.109.061853
9. Y Shao SR Cherry K Farahani K Meadors S Siegel RW Silverman, et al. 1997 Simultaneous PET and MR imaging Phys Med Biol 42 1965 1970 9364592 10.1088/0031-9155/42/10/010 1:STN:280:DyaK1c%2FjtFWktw%3D%3D (Pubitemid 27448997)
10. HP Schlemmer BJ Pichler M Schmand Z Burbar C Michel R Ladebeck, et al. 2008 Simultaneous MR/PET imaging of the human brain: feasibility study Radiology 248 1028 1035 18710991 10.1148/radiol.2483071927
11. RB Slates K Farahani Y Shao PK Marsden J Taylor PE Summers, et al. 1999 A study of artefacts in simultaneous PET and MR imaging using a prototype MR compatible PET scanner Phys Med Biol 44 2015 2027 10473211 10.1088/0031-9155/44/ 8/312 1:STN:280:DyaK1MvgtVWqsg%3D%3D (Pubitemid 29387608)
12. HF Wehrl MS Judenhofer S Wiehr BJ Pichler 2009 Pre-clinical PET/MR: technological advances and new perspectives in biomedical research Eur J Nucl Med Mol Imaging 36 Suppl 1 S56 S68 19194703 10.1007/s00259-009-1078-0
13. JW Fletcher SM Kymes M Gould N Alazraki RE Coleman VJ Lowe, et al. 2008 A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules J Nucl Med 49 179 185 18199626 10.2967/jnumed.107.044990 (Pubitemid 351225654)
14. W Yang Z Fu J Yu S Yuan B Zhang D Li, et al. 2008 Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer Lung Cancer 61 35 43 18177978 10.1016/j.lungcan.2007.11.007
15. J Czernin M Allen-Auerbach HR Schelbert 2007 Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006 J Nucl Med 48 Suppl 1 78S 88S 17204723 1:CAS:528:DC%2BD2sXitVamsrw%3D (Pubitemid 47604945)
16. W Chen W Jian HT Li C Li YK Zhang B Xie, et al. 2010 Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? Magn Reson Imaging 28 613 620 20418042 10.1016/j.mri.2010.02.009 1:CAS:528:DC%2BC3cXhsVCgs73I
17. M Van Goethem W Tjalma K Schelfout I Verslegers I Biltjes P Parizel 2006 Magnetic resonance imaging in breast cancer Eur J Surg Oncol 32 901 910 16920327 10.1016/j.ejso.2006.06.009 (Pubitemid 44636925)
18. TA Heusner S Kuemmel A Koeninger ME Hamami S Hahn A Quinsten, et al. 2010 Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging Eur J Nucl Med Mol Imaging 37 1077 1086 20204355 10.1007/s00259-010-1399-z
19. TA Heusner S Kuemmel L Umutlu A Koeninger LS Freudenberg EA Hauth, et al. 2008 Breast cancer staging in a single session: whole-body PET/CT mammography J Nucl Med 49 1215 1222 18632831 10.2967/jnumed.108.052050
20. Hofmann M, Pichler B, Schölkopf and Beyer T. Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nucl Med Mol Ima. 2009;36 Suppl 1: S93-104.
21. M Conti 2011 Focus on time-of-flight PET: the benefits of improved time resolution Eur J Nucl Med Mol Imaging 10.1007/s00259-010-1711-y Erratum doi: 10.1007/s00259-011-1763-7
22. BJ Pichler HF Wehrl MS Judenhofer 2008 Latest advances in molecular imaging instrumentation J Nucl Med 49 Suppl 2 5S 23S 18523063 10.2967/jnumed.108.045880 (Pubitemid 351948034)